Urinary proteomic shotgun approach for identification of potential acute rejection biomarkers in renal transplant recipients

Transplantation Research

Volumn 1, Issue 1, 2012, Pages

  Loftheim, Håvard ^a   Midtvedt, Karsten ^b   Hartmann, Anders ^b   Reisæter, Anna V ^b   Falck, Pål ^a   Holdaas, Hallvard ^b   Jenssen, Trond ^b   Reubsaet, Leon ^a   Åsberg, Anders ^a  

^a UNIVERSITY OF OSLO   (Norway)

^b OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

Acute rejection; Biomarker; Renal transplantation; Urinary proteomics

Indexed keywords

BASILIXIMAB; CYCLOSPORIN A; GALECTIN 3; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PROTEOME; STEROID;

ACUTE GRAFT REJECTION; ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED CLINICAL TRIAL (TOPIC); CONTROLLED STUDY; DISEASE ASSOCIATION; DOWN REGULATION; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; IMMUNE RESPONSE; KIDNEY TRANSPLANTATION; LIQUID CHROMATOGRAPHY; MALE; MASS SPECTROMETRY; MIDDLE AGED; PRIORITY JOURNAL; PROSPECTIVE STUDY; UPREGULATION; URINALYSIS;

EID: 84887266136     PISSN: None     EISSN: 20471440     Source Type: Journal    
DOI: 10.1186/2047-1440-1-9     Document Type: Article

References (51)

1. Almond PS, Matas A, Gillingham K, Dunn DL, Payne WD, Gores P, Gruessner R, Najarian JS, Ferguson, Paul, Schaffer. Risk-Factors for Chronic Rejection in Renal-Allograft Recipients. Transplantation 1993, 55(4):752-757. 10.1097/00007890-199304000-00013, 8475548.
2. Hariharan S, Johnson CP, Bresnahan BA, Taranto SE, McIntosh MJ, Stablein D. Improved Graft Survival after Renal Transplantation in the United States, 1988 to 1996. N Eng J Med 2000, 342(9):605-612.
3. Kaplan B. Overcoming barriers to long-term graft survival. Am J Kidney Dis 2006, 47(4):S52-S64. 10.1053/j.ajkd.2005.12.044, 16567241.
4. Meier-Kriesche HU, Ojo AO, Hanson JA, Cibrik DM, Punch JD, Leichtman AB, Kaplan B. Increased impact of acute rejection on chronic allograft failure in recent era. Transplantation 2000, 70(7):1098-1100. 10.1097/00007890-200010150-00018, 11045649.
5. Nankivell BJ, Chapman JR. Chronic allograft nephropathy: current concepts and future directions. Transplantation 2006, 81(5):643-654. 10.1097/01.tp.0000190423.82154.01, 16534463.
6. Racusen LC, Solez K, Colvin RB, Bonsib SM, Castro MC, Cavallo T, Croker BP, Demetris AJ, Drachenberg CB, Fogo AB, Furness P, Gaber LW, Gibson IW, Glotz D, Goldberg JC, Grande J, Halloran PF, Hansen HE, Hartley B, Hayry PJ, Hill CM, Hoffman EO, Hunsicker LG, Lindblad AS, Marcussen N, Mihatsch MJ, Nadasdy T, Nickerson P, Olsen TS, Papadimitriou JC, et al. The Banff 97 working classification of renal allograft pathology. Kidney Int 1999, 55(2):713-723. 10.1046/j.1523-1755.1999.00299.x, 9987096.
7. Reichelt O, Müller J, von Eggeling F, Driesch D, Wunderlich H, Schubert J, Gröne H-J, Stein G, Ott U, Junker K. Prediction of renal allograft rejection by urinary protein analysis using ProteinChip Arrays (surface-enhanced laser desorption/ionization time-of-flight mass spectrometry). Urology 2006, 67(3):472-475. 10.1016/j.urology.2005.09.038, 16527560.
8. Pieper R, Gatlin CL, McGrath AM, Makusky AJ, Mondal M, Seonarain M, Field E, Schatz CR, Estock MA, Ahmed N, Anderson NG, Steiner S. Characterization of the human urinary proteome: A method for high-resolution display of urinary proteins on two-dimensional electrophoresis gels with a yield of nearly 1400 distinct protein spots. Proteomics 2004, 4(4):1159-1174. 10.1002/pmic.200300661, 15048996.
9. Thongboonkerd V. Recent progress in urinary proteomics. Proteomics Clin Appl 2007, 1(8):780-791. 10.1002/prca.200700035, 21136734.
10. Brown FG, Nikolic-Paterson DJ, Chadban SJ, Dowling J, Jose M, Metz CN, Bucala R, Atkins RC. Urine macrophage migration inhibitory factor concentrations as a diagnostic tool in human renal allograft rejection. Transplantation 2001, 71(12):1777-1783. 10.1097/00007890-200106270-00013, 11455258.
11. Donadio C, Puccini R, Lucchesi A, Giordani R, Rizzo G. Urinary excretion of proteins and tubular enzymes in renal transplant patients. Ren Fail 1998, 20(5):707-715. 10.3109/08860229809045167, 9768439.
12. Gupta RK, Jain M, Sharma RK. Serum & urinary interleukin-2 levels as predictors in acute renal allograft rejection. Indian J Med Res 2004, 119:24-27.
13. Hauser IA, Spiegler S, Kiss E, Gauer S, Sichler O, Scheuermann EH, Ackermann H, Pfeilschifter JM, Geiger H, Gröne H-J, Radeke HH. Prediction of Acute Renal Allograft Rejection by Urinary Monokine Induced by IFN-γ (MIG). J Am Soc Nephrol 2005, 16(6):1849-1858. 10.1681/ASN.2004100836, 15857922.
14. Hu H, Aizenstein BD, Puchalski A, Burmania JA, Hamawy MM, Knechtle SJ. Elevation of CXCR3-Binding Chemokines in Urine Indicates Acute Renal-Allograft Dysfunction. Am J Transplant 2004, 4(3):432-437. 10.1111/j.1600-6143.2004.00354.x, 14961998.
15. Kaden J, Priesterjahn R. Increasing urinary IL-6 levels announce kidney graft rejection. Transpl Int 2000, 13:S34-S41.
16. Lederer SR, Friedrich N, Regenbogen C, Getto R, Toepfer M, Sitter T. Non-Invasive Monitoring of Renal Transplant Recipients: Urinary Excretion of Soluble Adhesion Molecules and of the Complement-Split Product C4d. Nephron Clin Pract 2003, 94(1):c19-c26. 10.1159/000070820, 12806188.
17. Matz M, Beyer J, Wunsch D, Mashreghi MF, Seiler M, Pratschke J, Babel N, Volk HD, Reinke P, Kotsch K. Early post-transplant urinary IP-10 expression after kidney transplantation is predictive of short- and long-term graft function. Kidney Int 2006, 69(9):1683-1690. 10.1038/sj.ki.5000343, 16572110.
18. Oetting WS, Rogers TB, Krick TP, Matas AJ, Ibrahim HN. Urinary beta(2)-microglobulin is associated with acute renal allograft rejection. Am J Kidney Dis 2006, 47(5):898-904. 10.1053/j.ajkd.2006.01.034, 16632030.
19. Roelofs JJTH, Rowshani AT, Van Den Berg JG, Claessen N, Aten J, Ten Berge IJM, Weening JJ, Florquin S. Expression of urokinase plasminogen activator and its receptor during acute renal allograft rejection. Kidney Int 2003, 64(5):1845-1853. 10.1046/j.1523-1755.2003.00261.x, 14531820.
20. Sigdel TK, Kaushal A, Gritsenko M, Norbeck AD, Qian W-J, Xiao W, Camp DG, Smith RD, Sarwal MM. Shotgun proteomics identifies proteins specific for acute renal transplant rejection. Proteomics Clin Appl 2010, 4(1):32-47. 10.1002/prca.200900124, 2883247, 20543976.
21. Teppo AM, von Willebrand E, Honkanen E, Ahonen J, Gronhagen-Riska C. Soluble intercellular adhesion molecule-1 (sICAM-1) after kidney transplantation: The origin and role of urinary sICAM-1?. Transplantation 2001, 71(8):1113-1119. 10.1097/00007890-200104270-00018, 11374412.
22. Clarke W, Silverman BC, Zhang Z, Chan DW, Klein AS, Molmenti EP. Characterization of renal allograft rejection by urinary proteomic analysis. Ann Surg 2003, 237(5):660-664. 1514509, 12724632.
23. Schaub S, Rush D, Wilkins J, Gibson IW, Weiler T, Sangster K, Nicolle L, Karpinski M, Jeffry J, Nickerson P. Proteomic-based detection of urine proteins associated with acute renal allograft rejection. J Am Soc Nephrol 2004, 15(1):219-227. 10.1097/01.ASN.0000101031.52826.BE, 14694176.
24. Wittke S, Haubitz M, Walden M, Rohde F, Schwarz A, Mengel M, Mischak H, Haller H, Gwinner W. Detection of acute tubulointerstitial rejection by proteomic analysis of urinary samples in renal transplant recipients. Am J Transplant 2005, 5(10):2479-2488. 10.1111/j.1600-6143.2005.01053.x, 16162198.
25. Gwinner W. Renal transplant rejection markers. World J Urol 2007, 25(5):445-455. 10.1007/s00345-007-0211-6, 17786452.
26. Thongboonkerd V, Malasit P. Renal and urinary proteomics: Current applications and challenges. Proteomics 2005, 5(4):1033-1042. 10.1002/pmic.200401012, 15669002.
27. Falck P, Asberg A, Guldseth H, Bremer S, Akhlaghi F, Reubsaet JLE, Pfeffer P, Hartmann A, Midtvedt K. Declining intracellular T-lymphocyte concentration of cyclosporine a precedes acute rejection in kidney transplant recipients. Transplantation 2008, 85(2):179-184. 10.1097/TP.0b013e31815feede, 18212621.
28. Loftheim H, Nguyen TD, Malerød H, Lundanes E, Åsberg A, Reubsaet L. 2-D hydrophilic interaction liquid chromatography-RP separation in urinary proteomics - Minimizing variability through improved downstream workflow compatibility. J Sep Sci 2010, 33(6-7):864-872.
29. Loftheim H, Åsberg A, Reubsaet L. Accelerated 18O-labeling in urinary proteomics. J Chromatogr A 2010, 1217(52):8241-8248. 10.1016/j.chroma.2010.10.119, 21094492.
30. Bradford MM. Rapid and Sensitive Method for Quantitation of Microgram Quantities of Protein Utilizing Principle of Protein-Dye Binding. Anal Biochem 1976, 72(1-2):248-254.
31. Eng JK, McCormack AL, Yates JR. An Approach to Correlate Tandem Mass-Spectral Data of Peptides with Amino-Acid-Sequences in a Protein Database. J Am Soc Mass Spectrom 1994, 5(11):976-989.
32. Leng L, Metz CN, Fang Y, Xu J, Donnelly S, Baugh J, Delohery T, Chen Y, Mitchell RA, Bucala R. MIF Signal Transduction Initiated by Binding to CD74. J Exp Med 2003, 197(11):1467-1476. 10.1084/jem.20030286, 2193907, 12782713.
33. Lan HY. Role of Macrophage Migration Inhibition Factor in Kidney Disease. Nephron Exp Nephrol 2008, 109(3):e79-e83. 10.1159/000145463, 18663334.
34. Borghese F, Clanchy FI. CD74: an emerging opportunity as a therapeutic target in cancer and autoimmune disease. Expert Opin Ther Targets 2011, 15(3):237-251. 10.1517/14728222.2011.550879, 21208136.
35. Kumar P, Kodlin D, Marks C, Leech SH. Predictive value of serum complement (C3) in renal allograft rejection. Br J Surg 1980, 67(7):500-502. 10.1002/bjs.1800670716, 6998539.
36. Tang S, Zhou W, Sheerin NS, Vaughan RW, Sacks SH. Contribution of Renal Secreted Complement C3 to the Circulating Pool in Humans. J Immunol 1999, 162(7):4336-4341.
37. Segarra A. Progress in understanding the pathogenesis of IgA nephropathy: New perspectives for the near future?. Nefrologia 2010, 30(5):501-507.
38. Panichi V, Migliori M, De Pietro S, Taccola D, Andreini B, Metelli MR, Giovannini L, Palla R. The link of biocompatibility to cytokine production. Kidney Int 2000, 58(S76):S96-S103.
39. Matsushita M, Thiel S, Jensenius JC, Terai I, Fujita T. Proteolytic Activities of Two Types of Mannose-Binding Lectin-Associated Serine Protease. J Immunol 2000, 165(5):2637-2642.
40. Tamura K, Hashimoto K, Suzuki K, Yoshie M, Kutsukake M, Sakurai T. Insulin-like growth factor binding protein-7 (IGFBP7) blocks vascular endothelial cell growth factor (VEGF)-induced angiogenesis in human vascular endothelial cells. Eur J Pharmacol 2009, 610(1-3):61-67.
41. Nagakubo D, Murai T, Tanaka T, Usui T, Matsumoto M, Sekiguchi K, Miyasaka M. A High Endothelial Venule Secretory Protein, Mac25/Angiomodulin, Interacts with Multiple High Endothelial Venule-Associated Molecules Including Chemokines. J Immunol 2003, 171(2):553-561.
42. Usui T, Murai T, Tanaka T, Yamaguchi K, Nagakubo D, Lee CM, Kiyomi M, Tamura S, Matsuzawa Y, Miyasaka M. Characterization of mac25/angiomodulin expression by high endothelial venule cells in lymphoid tissues and its identification as an inducible marker for activated endothelial cells. Int Immunol 2002, 14(11):1273-1282. 10.1093/intimm/dxf102, 12407018.
43. Campistol JM, Iñigo P, Larios S, Bescos M, Oppenheimer F. Role of transforming growth factor-β1 in the progression of chronic allograft nephropathy. Nephrol Dial Transplant 2001, 16(suppl 1):114-116. 10.1093/ndt/16.suppl_1.114, 11568266.
44. Ikeda Y, Imai Y, Kumagai H, Nosaka T, Morikawa Y, Hisaoka T, Manabe I, Maemura K, Nakaoka T, Imamura T, Miyazono K, Komuro I, Nagai R, Kitamura T. Vasorin, a transforming growth factor β-binding protein expressed in vascular smooth muscle cells, modulates the arterial response to injury in vivo. Proc Natl Acad Sci USA 2004, 101(29):10732-10737. 10.1073/pnas.0404117101, 490003, 15247411.
45. Shihab FS, Tanner AM, Shao Y, Weffer MI. Expression of TGF-[beta]1 and matrix proteins is elevated in rats with chronic rejection. Kidney Int 1996, 50(6):1904-1913. 10.1038/ki.1996.512, 8943473.
46. Fukaya Y, Shimada H, Wang L-C, Zandi E, DeClerck YA. Identification of Galectin-3-binding Protein as a Factor Secreted by Tumor Cells That Stimulates Interleukin-6 Expression in the Bone Marrow Stroma. J Biol Chem 2008, 283(27):18573-18581. 10.1074/jbc.M803115200, 18450743.
47. Ullrich A, Sures I, D'Egidio M, Jallal B, Powell TJ, Herbst R, Dreps A, Azam M, Rubinstein M, Natoli C. The secreted tumor-associated antigen 90 K is a potent immune stimulator. J Biol Chem 1994, 269(28):18401-18407.
48. Di Paolo S, Gesualdo L, Stallone G, Ranieri E, Schena FP. Renal expression and urinary concentration of EGF and IL-6 in acutely dysfunctioning kidney transplanted patients. Nephrol Dial Transplant 1997, 12(12):2687-2693. 10.1093/ndt/12.12.2687, 9430873.
49. O'Riordan E, Orlova TN, Podust VN, Chander PN, Yanagi S, Nakazato M, Hu R, Butt K, Delaney V, Goligorsky MS. Characterization of urinary peptide biomarkers of acute rejection in renal allografts. Am J Transplant 2007, 7(4):930-940. 10.1111/j.1600-6143.2007.01733.x, 17331118.
50. Nickerson P, Jeffery J, Gough J, Grimm P, Mckenna R, Birk P, Rush D. Effect of Increasing Baseline Immunosuppression on the Prevalence of Clinical and Subclinical Rejection: A Pilot Study. J Am Soc Nephrol 1999, 10(8):1801-1805.
51. Rush DN, Henry SF, Jeffery JR, Schroeder TJ, Gough J. Histological-findings in early routine biopsies of stable renal-allograft recipients. Transplantation 1994, 57(2):208-211. 10.1097/00007890-199401001-00009, 8310509.